NCT02277171View on ClinicalTrials.gov

Evaluation of Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

September 30, 2015

Conditions
Urinary Tract InfectionBacteriuria
Interventions
DEVICE

Nitric Oxide impregnated catheter

Patients undergoing radical prostatectomy will be catheterized for 7-14 days with Nitric Oxide impregnated Foley catheters

All Listed Sponsors
collaborator

Rabin Medical Center

OTHER

lead

Enox Israel Ltd

INDUSTRY

NCT02277171 - Evaluation of Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters | Biotech Hunter | Biotech Hunter